Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e000875
Publisher
BMJ
Online
2020-08-17
DOI
10.1136/jitc-2020-000875
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
- (2019) Pieter Goossens et al. Cell Metabolism
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
- (2019) Huiyan Cheng et al. Frontiers in Oncology
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
- (2018) Janos L. Tanyi et al. Science Translational Medicine
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
- (2017) Chloe Chong et al. MOLECULAR & CELLULAR PROTEOMICS
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
- (2016) Phillip P. Santoiemma et al. GYNECOLOGIC ONCOLOGY
- The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization
- (2016) Florian Finkernagel et al. Oncotarget
- Interleukin 10 (IL-10)-mediated Immunosuppression
- (2015) Sharad K. Mittal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
- (2013) C. L.-L. Chiang et al. CLINICAL CANCER RESEARCH
- A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
- (2013) Lana E Kandalaft et al. Journal of Translational Medicine
- Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
- (2013) Lana E. Kandalaft et al. OncoImmunology
- Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer
- (2012) V Harding et al. BRITISH JOURNAL OF CANCER
- Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice
- (2012) Ioannis F. Voutsas et al. EUROPEAN JOURNAL OF CANCER
- Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
- (2012) Uciane K. Scarlett et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer
- (2012) Eduardo Batista Cândido et al. Reproductive Sciences
- Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
- (2011) Cheryl L-L Chiang et al. Journal of Translational Medicine
- Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses
- (2011) Cheryl Lai-Lai Chiang et al. PLoS One
- IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
- (2011) Kevin M. Hart et al. Frontiers in Immunology
- Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines
- (2010) Eric Tran et al. PLoS One
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive Immunity
- (2009) Z. M. Prokopowicz et al. JOURNAL OF IMMUNOLOGY
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started